• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astal Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4277.0
  • ISIN : INE307N01014
76.90 -3 (-3.20%)
  • As on 05 Sep 2026 (EOD)

  • Today’s Low

    74.05

  • Today’s High

    80.35

  • Open

    80.35

  • Perv Close

    79.44

  • 52W Low

    60.45

  • 52W High

    103.20

Key Indicators

  • P/E(TTM)

    34.64

  • Mar.Cap (₹Cr.)

    336.81

  • Div & Yield %

    0.00

  • Book Value(₹)

    76.14

  • Debt-Equity Ratio

    -3.20

  • AGM Date

    04-Sep-2026

  • EPS

    2.22

  • P/E Ratio

    34.64

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    336.81

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.80

  • BV (₹)

    76.10

  • Sales( ₹ in Cr.)

    156.00

  • NP (in Cr.)

    8.12

  • NP Var(%)

    -9.0

  • Div%

    0.0

  • CPS (₹)

    2.00

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    336.81

  • 52 Week High

    103.20

  • 52 Week Low

    60.45

  • Price BSE

    77.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    336.81

  • P/C Ratio

    38.30

  • P/E Ratio

    41.60

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 64.23 23.65 3.43 0.00 0.20 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 64.23 23.65 3.43 0.00 0.20 0.00
Other Income 0.13 0.01 0.18 0.21 0.00 0.20
Stock Adjustments 13.70 1.06 0.00 0.00 0.00 0.00
Total Income 78.06 24.72 3.61 0.21 0.20 0.20
EXPENDITURE :            
Raw Materials 61.81 22.40 3.35 0.00 0.00 0.00
Power and Fuel Cost 0.14 0.02 0.01 0.02 0.01 0.02
Employee Cost 1.26 0.47 0.06 0.09 0.06 0.09
Other Manufacturing Expenses 0.37 0.00 0.01 0.01 0.01 0.01
Selling and Administration Expenses 1.57 0.71 0.13 0.10 0.10 0.10
Miscellaneous Expenses 0.00 0.00 0.00 0.01 0.00 0.00
Employee Benefit Expenses 1.26 0.47 0.06 0.09 0.06 0.09
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 65.15 23.59 3.56 0.21 0.18 0.22
Operating Profit 12.90 1.13 0.04 0.00 0.02 -0.01
Interest 0.70 0.01 0.00 0.00 0.00 0.00
Gross Profit 12.20 1.12 0.04 0.00 0.02 -0.01
Depreciation 0.22 0.03 0.01 0.01 0.02 0.02
Profit Before Tax 11.98 1.09 0.03 -0.01 0.00 -0.03
Current Tax 2.94 0.29 0.01 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.11 0.01 0.01 0.00 0.00 0.00
Reported Net Profit 8.93 0.78 0.02 -0.02 0.01 -0.03
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 8.93 0.78 0.02 -0.02 0.01 -0.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1.78 0.99 0.98 0.99 0.99 1.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 10.70 1.78 0.99 0.98 0.99 0.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.07 0.80 0.04 -0.04 0.02 -0.07
Earnings Per Share(Adj)-Unit Curr 9.07 0.80 0.04 -0.04 0.02 -
Book Value 32.77 23.71 12.98 12.93 12.97 12.96
Book Value(Adj)-Unit Curr 32.77 23.71 12.98 12.93 12.97 -

Shareholding Pattern

  • Promoter Group

    4.53%

  • Public Share Holding

    95.47%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,985,595 4.53 1,985,595 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,985,595 4.53 1,985,595 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,221,917 2.79 1,184,717 27
Clearing Members 2,000 0.00 2,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,148,233 9.47 4,148,233 37
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 733,310 1.67 733,310 49
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 32,346,625 73.85 32,346,625 162
Individuals holding nominal share capital up to Rs. 1 lakh 3,076,318 7.02 2,712,098 2,992
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 41,813,337 95.47 41,411,917 3,273
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,798,932 100.00 43,397,512 3,274

Company Background

Astal Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Astal Laboratories Ltd
  • BSE Code : 4277.0
  • ISIN : INE307N01014

  • Incorporation Year

    1993

  • Registered Office

    House No 4-50/1 Sy No 134 132
    Block B 8th Floor Flat No 801, Hyderabad,
    Telangana-500032

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Mahendra Kumar

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    99 BeetalHouse 3rd F,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

Astal Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astal Lab 76.90 64.36 64.23 34.64 34.78
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 398.23 356.27 41.34 16.64
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77